Θεοδώρα Κάτσιλα

National Hellenic Research Foundation — Greece

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

26h-index2.9kcitations164works7.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(23), Colorectal Cancer Treatments and Studies(21), Cancer Genomics and Diagnostics(17), Genomics and Rare Diseases(17), Computational Drug Discovery Methods(11)

Publications159 total

Computational Methods for Cancer Neoantigen Prediction
Methods in molecular biology·2025Open Access
Using Epigenetic Data to Deconvolute Immune Cells in Cancer from Blood Samples
Methods in molecular biology·2025Open Access
Deciphering the Tumor Microenvironment Composition Using Bulk Transcriptomics: A Guide to Recent Advances and Open Challenges
Methods in molecular biology·2025Open Access
Intepirdine Derivatives Possessing Dual 5HT6 Antagonism / HDAC6 Inhibitory Activity
Chemistry - A European Journal·2025Open Access
Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling
Frontiers in Immunology·2025· 22 citedOpen Access
CAR Exosome-Based Therapeutics
2025
An Expert Consensus Statement on Biomarkers of Aging for Use in Intervention Studies
The Journals of Gerontology Series A·2024· 12 citedOpen Access
AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors
Journal of Chemical Information and Modeling·2024· 6 citedOpen Access
Metabolic Reprogramming in Myelodysplastic Syndromes
Blood·2024· 1 citedOpen Access
Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC
Cancers·2024· 4 citedOpen Access
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for <i>OMICS: A Journal of Integrative Biology</i>
OMICS A Journal of Integrative Biology·2024
Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease
Stem Cell Research & Therapy·2024· 10 citedOpen Access
Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins
International Journal of Molecular Sciences·2024· 6 citedOpen Access
Clinical implementation of preemptive pharmacogenomics in psychiatry
EBioMedicine·2024· 49 citedOpen Access
Data-Driven Drug Repurposing in Diabetes Mellitus through an Enhanced Knowledge Graph
2023· 3 citedOpen Access
Cloudscreen: A “one-stop-shop” Platform for Drug Repurposing
2023Open Access
A quest for the stereo-electronic requirements for selective agonism for the neurotrophin receptors TrkA and TrkB in 17-spirocyclic-dehydroepiandrosterone derivatives
Frontiers in Molecular Neuroscience·2023· 5 citedOpen Access
A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing
OMICS A Journal of Integrative Biology·2023· 15 citedOpen Access
Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s Disease.
2023Open Access
BNN27 nanoformulations for nose-to-brain delivery
2023· 3 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

George P. Patrinos(35), Konstantinos Mitropoulos(8), Christina Mitropoulou(7), Constantin Tamvakopoulos(6), Clint Mizzi(5), Angeliki Balasopoulou(5), Cristiana Pavlidis(5), Minos–Timotheos Matsoukas(4), Joseph Borg(4), Sonja Pavlović(4), Branka Zukić(4), Constantina Chalikiopoulou(4), Evangelia Eirini Tsermpini(4), D.N. Cooper(4), Ioanna Papantoni(3), Alessio Squassina(3), Peter J. van der Spek(3), Brock A. Peters(3), Radoje Drmanac(3), Alexandros Siskos(3)